{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:13:20Z","timestamp":1767140000598,"version":"build-2238731810"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T00:00:00Z","timestamp":1450137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00105-015-3735-5","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T02:13:12Z","timestamp":1450145592000},"page":"69-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pathogenese, Klinik und aktuelle Therapie der Rosazea","Pathogenesis, clinical picture, and current therapy of rosacea"],"prefix":"10.1007","volume":"67","author":[{"given":"L.I.","family":"Gonser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Gonser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,15]]},"reference":[{"key":"3735_CR1","first-page":"996","volume":"7","author":"K Gauwerky","year":"2009","unstructured":"Gauwerky K, Klovekorn W, Korting HC et al (2009) Rosacea. J Dtsch Dermatol Ges 7:996\u20131003","journal-title":"J Dtsch Dermatol Ges"},{"key":"3735_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","volume":"15","author":"M Steinhoff","year":"2011","unstructured":"Steinhoff M, Buddenkotte J, Aubert J et al (2011) Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 15:2\u201311","journal-title":"J Investig Dermatol Symp Proc"},{"key":"3735_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","volume":"55","author":"K Yamasaki","year":"2009","unstructured":"Yamasaki K, Gallo RL (2009) The molecular pathology of rosacea. J Dermatol Sci 55:77\u201381","journal-title":"J Dermatol Sci"},{"key":"3735_CR4","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1016\/j.jaci.2009.07.014","volume":"124","author":"J Schauber","year":"2009","unstructured":"Schauber J, Gallo RL (2009) Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 124:R13\u2013R18","journal-title":"J Allergy Clin Immunol"},{"key":"3735_CR5","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","volume":"20","author":"K Yamasaki","year":"2006","unstructured":"Yamasaki K, Schauber J, Coda A et al (2006) Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 20:2068\u20132080","journal-title":"FASEB J"},{"key":"3735_CR6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","volume":"13","author":"K Yamasaki","year":"2007","unstructured":"Yamasaki K, Di Nardo A, Bardan A et al (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975\u2013980","journal-title":"Nat Med"},{"key":"3735_CR7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","volume":"131","author":"K Yamasaki","year":"2011","unstructured":"Yamasaki K, Kanada K, Macleod DT et al (2011) TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol 131:688\u2013697","journal-title":"J Invest Dermatol"},{"key":"3735_CR8","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1365-2133.2012.11096.x","volume":"167","author":"EC Sattler","year":"2012","unstructured":"Sattler EC, Maier T, Hoffmann VS et al (2012) Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy. Br J Dermatol 167:1042\u20131047","journal-title":"Br J Dermatol"},{"key":"3735_CR9","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/bjd.12850","volume":"170","author":"W Chen","year":"2014","unstructured":"Chen W, Plewig G (2014) Human demodicosis: revisit and a proposed classification. Br J Dermatol 170:1219\u20131225","journal-title":"Br J Dermatol"},{"key":"3735_CR10","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2567.2007.02705.x","volume":"123","author":"M Kulka","year":"2008","unstructured":"Kulka M, Sheen CH, Tancowny BP et al (2008) Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123:398\u2013410","journal-title":"Immunology"},{"key":"3735_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","volume":"15","author":"VD Schwab","year":"2011","unstructured":"Schwab VD, Sulk M, Seeliger S et al (2011) Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc 15:53\u201362","journal-title":"J Investig Dermatol Symp Proc"},{"key":"3735_CR12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00105-005-1009-3","volume":"56","author":"P Lehmann","year":"2005","unstructured":"Lehmann P (2005) [Rosacea. Clinical features, pathogenesis and therapy]. Hautarzt 56:871\u2013885. (quiz 886\u2013887)","journal-title":"Hautarzt"},{"key":"3735_CR13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","volume":"46","author":"J Wilkin","year":"2002","unstructured":"Wilkin J, Dahl M, Detmar M et al (2002) Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 46:584\u2013587","journal-title":"J Am Acad Dermatol"},{"key":"3735_CR14","first-page":"1218","volume-title":"Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie","author":"BJT Melnik","year":"2012","unstructured":"Melnik BJT (2012) Akne und Rosazea. In: Plewig G Landthaler M, Burgdorf W, Hertl M, Ruzicka T (Hrsg) Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie. Springer, Berlin, S\u00a01218\u20131225"},{"key":"3735_CR15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1365-2133.2012.11037.x","volume":"167","author":"J Spoendlin","year":"2012","unstructured":"Spoendlin J, Voegel JJ, Jick SS et al (2012) A study on the epidemiology of rosacea in the U.K. Br J Dermatol 167:598\u2013605","journal-title":"Br J Dermatol"},{"issue":"768\u2013780","key":"3735_CR16","first-page":"768","volume":"11","author":"M Reinholz","year":"2013","unstructured":"Reinholz M, Tietze JK, Kilian K et al (2013) Rosacea \u2013 S1 guideline. J Dtsch Dermatol Ges 11(768\u2013780):768\u2013779","journal-title":"J Dtsch Dermatol Ges"},{"key":"3735_CR17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1525-1470.1992.tb00320.x","volume":"9","author":"B Drolet","year":"1992","unstructured":"Drolet B, Paller AS (1992) Childhood rosacea. Pediatr Dermatol 9:22\u201326","journal-title":"Pediatr Dermatol"},{"key":"3735_CR18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archdermatol.2007.50","volume":"144","author":"M Chamaillard","year":"2008","unstructured":"Chamaillard M, Mortemousque B, Boralevi F et al (2008) Cutaneous and ocular signs of childhood rosacea. Arch Dermatol 144:167\u2013171","journal-title":"Arch Dermatol"},{"key":"3735_CR19","first-page":"920","volume":"12","author":"S Seite","year":"2013","unstructured":"Seite S, Benech F, Berdah S et al (2013) Management of rosacea-prone skin: evaluation of a skincare product containing Ambophenol, Neurosensine, and La Roche-Posay Thermal spring water as monotherapy or adjunctive therapy. J Drugs Dermatol 12:920\u2013924","journal-title":"J Drugs Dermatol"},{"key":"3735_CR20","unstructured":"Liste R (2015)"},{"key":"3735_CR21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2133.2011.10473.x","volume":"165","author":"EJ Zuuren Van","year":"2011","unstructured":"Van Zuuren EJ, Kramer SF, Carter BR et al (2011) Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review. Br J Dermatol 165:760\u2013781","journal-title":"Br J Dermatol"},{"key":"3735_CR22","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2011.10716.x","volume":"166","author":"J Fowler","year":"2012","unstructured":"Fowler J, Jarratt M, Moore A et al (2012) Once-daily topical brimonidine tartrate gel 0.5\u2009% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol 166:633\u2013641","journal-title":"Br J Dermatol"},{"key":"3735_CR23","first-page":"56","volume":"13","author":"A Moore","year":"2014","unstructured":"Moore A, Kempers S, Murakawa G et al (2014) Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5\u2009% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study. J Drugs Dermatol 13:56\u201361","journal-title":"J Drugs Dermatol"},{"key":"3735_CR24","first-page":"149","volume":"80","author":"KJ Allen","year":"2007","unstructured":"Allen KJ, Davis CL, Billings SD et al (2007) Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin. Cutis 80:149\u2013151","journal-title":"Cutis"},{"key":"3735_CR25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2133.1998.02125.x","volume":"138","author":"F Forton","year":"1998","unstructured":"Forton F, Seys B, Marchal JL et al (1998) Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy. Br J Dermatol 138:461\u2013466","journal-title":"Br J Dermatol"},{"key":"3735_CR26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000065849","volume":"205","author":"M Kocak","year":"2002","unstructured":"Kocak M, Yagli S, Vahapoglu G et al (2002) Permethrin 5\u2009% cream versus metronidazole 0.75\u2009% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology 205:265\u2013270","journal-title":"Dermatology"},{"key":"3735_CR27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1067\/mjd.2001.114739","volume":"44","author":"D Goldman","year":"2001","unstructured":"Goldman D (2001) Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 44:995\u2013998","journal-title":"J Am Acad Dermatol"},{"key":"3735_CR28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2006.11.021","volume":"56","author":"JQ Del Rosso","year":"2007","unstructured":"Del Rosso JQ, Webster GF, Jackson M et al (2007) Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol 56:791\u2013802","journal-title":"J Am Acad Dermatol"},{"key":"3735_CR29","first-page":"904","volume":"9","author":"I Pfeffer","year":"2011","unstructured":"Pfeffer I, Borelli C, Zierhut M et al (2011) Treatment of ocular rosacea with 40\u00a0mg doxycycline in a slow release form. J Dtsch Dermatol Ges 9:904\u2013907","journal-title":"J Dtsch Dermatol Ges"},{"key":"3735_CR30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1046\/j.1365-4362.1997.00301.x","volume":"36","author":"C Torresani","year":"1997","unstructured":"Torresani C, Pavesi A, Manara GC (1997) Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol 36:942\u2013946","journal-title":"Int J Dermatol"},{"key":"3735_CR31","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0190-9622(03)00743-6","volume":"49","author":"M Schaller","year":"2003","unstructured":"Schaller M, Sander CA, Plewig G (2003) Demodex abscesses: clinical and therapeutic challenges. J Am Acad Dermatol 49:S272\u2013S274","journal-title":"J Am Acad Dermatol"},{"key":"3735_CR32","first-page":"54","volume":"4","author":"H Park","year":"2011","unstructured":"Park H, Del Rosso JQ (2011) Use of oral isotretinoin in the management of rosacea. J Clin Aesthet Dermatol 4:54\u201361","journal-title":"J Clin Aesthet Dermatol"},{"key":"3735_CR33","first-page":"505","volume":"8","author":"H Gollnick","year":"2010","unstructured":"Gollnick H, Blume-Peytavi U, Szabo EL et al (2010) Systemic isotretinoin in the treatment of rosacea \u2013 doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges 8:505\u2013515","journal-title":"J Dtsch Dermatol Ges"},{"key":"3735_CR34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2012.04.017","volume":"67","author":"CC Hsu","year":"2012","unstructured":"Hsu CC, Lee JY (2012) Pronounced facial flushing and persistent erythema of rosacea effectively treated by carvedilol, a nonselective beta-adrenergic blocker. J Am Acad Dermatol 67:491\u2013493","journal-title":"J Am Acad Dermatol"}],"updated-by":[{"DOI":"10.1007\/s00105-016-3786-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000}}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-015-3735-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-015-3735-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-015-3735-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:40:48Z","timestamp":1558568448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-015-3735-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["3735"],"URL":"https:\/\/doi.org\/10.1007\/s00105-015-3735-5","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,15]]}}}